Cytokinetics | CYTK - Gross Profit On Sales

Stock Price
62.34
Daily Change
2.10 3.49%
Monthly
-4.71%
Yearly
45.79%
Q1 Forecast
61.24

Cytokinetics reported $1.94M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 256.99M 13.15M Sep/2025
Amgen USD 6.48B 307M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Cytokinetics USD 1.94M 64.83M Sep/2025
Eisai JPY 151.84B 8.21B Sep/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Exelixis USD 579.18M 30.39M Sep/2025
Geron USD 46.18M 1.66M Sep/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
Ligand Pharmaceuticals USD 155.28M 82.42M Sep/2025
Merck USD 13.42B 431M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025